Silvia Sookoian

Active 1999–2026

94
Papers
21,630
Citations
65
h-index
90
i10-index

Citations

Citations per year for Silvia Sookoian1995: 1 citations1997: 1 citations2001: 11 citations2002: 5 citations2003: 7 citations2004: 3 citations2005: 3 citations2006: 4 citations2007: 9 citations2008: 32 citations2009: 40 citations2010: 74 citations2011: 68 citations2012: 78 citations2013: 112 citations2014: 115 citations2015: 150 citations2016: 179 citations2017: 152 citations2018: 146 citations2019: 429 citations2020: 825 citations2021: 921 citations2022: 825 citations2023: 740 citations2024: 1,865 citations2025: 1,143 citations2026: 37 citations1996: no citations, so this year is not shown1998–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,850 citing papers, 16.5% of this breakdownChina: 1,707 citing papers, 15.2% of this breakdownItaly: 761 citing papers, 6.8% of this breakdownUnited Kingdom: 603 citing papers, 5.4% of this breakdownGermany: 410 citing papers, 3.7% of this breakdownSpain: 389 citing papers, 3.5% of this breakdownSouth Korea: 350 citing papers, 3.1% of this breakdownJapan: 324 citing papers, 2.9% of this breakdownAustralia: 293 citing papers, 2.6% of this breakdownFrance: 271 citing papers, 2.4% of this breakdownCanada: 210 citing papers, 1.9% of this breakdownSweden: 201 citing papers, 1.8% of this breakdown
0%16.5%Other 34.2%

Fields

  • Medicine79.8%
  • Biochemistry, Genetics and Molecular Biology12%
  • Neuroscience2.9%
  • Psychology1.1%
  • Immunology and Microbiology0.9%
  • Environmental Science0.7%
  • Other2.6%

Topics

  • Liver Disease Diagnosis and Treatment24.1%
  • Diet, Metabolism, and Disease6.6%
  • Liver Disease and Transplantation5.4%
  • Diabetes, Cardiovascular Risks, and Lipoproteins3.8%
  • Alcohol Consumption and Health Effects3.8%
  • Diet and metabolism studies2.6%
  • Other53.7%

Coauthors

All papers

Open in search
  1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome, on behalf of the NAFLD Nomenclature consensus group - Hepatology 2023 cited by 2,904

  2. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi - Gastroenterology 2020 cited by 3,274

  3. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome - Annals of Hepatology 2023 cited by 2,698

  4. Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease

    Authors: , , , , - Journal of Hepatology 2022 cited by 279

  5. Nonalcoholic fatty liver disease

    Authors: , , , , , , , , , - Nature Reviews Disease Primers 2015 cited by 841

  6. Global burden of metabolic diseases, 1990–2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leon A. Adams, Said A. Al‐Busafi, Ala I. Sharara, Wah‐Kheong Chan, Syed Imran Abbas, Silvia Sookoian, Sombat Treeprasertsuk, Ponsiano Ocama, Khalid Alswat, Alice P.S. Kong, Karim Ataya, Michelle Ching Lim-Loo, Rodolfo J. Oviedo, Olivia Szepietowski, Yasser Fouad, Huijie Zhang, Tamer N Abdelbaki, Christos S. Katsouras, Arun Prasad, Omar Thaher, Arshad Ali, Gabriel A Molina, Ki‐Chul Sung, Qin‐Fen Chen, Cosmas Rinaldi Adithya Lesmana, Ming‐Hua Zheng - Metabolism 2024 cited by 302

  7. Noninvasive biomarkers in NAFLD and NASH — current progress and future promise

    Authors: , , , , - Nature Reviews Gastroenterology & Hepatology 2018 cited by 620

  8. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

    Authors: , - Hepatology 2011 cited by 910

  9. From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease

    Authors: , - Journal of Lipid Research 2023 cited by 207

  10. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasser Fouad, Christos S. Mantzoros, Huijie Zhang, Nahúm Méndez‐Sánchez, Silvia Sookoian, Wah‐Kheong Chan, Sombat Treeprasertsuk, Leon A. Adams, Ponsiano Ocama, John Ryan, Nilanka Perera, Ala I. Sharara, Said A. Al‐Busafi, Christopher Opio, Manuel Garcia, Michelle Ching Lim-Loo, Elena Ruiz‐Úcar, Arun Prasad, Anna Casajoana, Tamer N. Abdelbaki, Ming‐Hua Zheng - EClinicalMedicine 2024 cited by 191

  11. Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease

    Authors: , , , , , , - Gut 2020 cited by 221

  12. Geographical similarity and differences in the burden and genetic predisposition of NAFLD

    Authors: , , , , , , , , - Hepatology 2022 cited by 120

  13. An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ajay Duseja, Adriaan G. Holleboom, Junping Shi, Wah‐Kheong Chan, Yasser Fouad, Junwei Yang, Sombat Treeprasertsuk, Helena Cortez‐Pinto, Masahide Hamaguchi, Manuel Romero‐Gómez, Mamun Al Mahtab, Ponsiano Ocama, Atsushi Nakajima, Chunsun Dai, Mohammed Eslam, Lai Wei, Jacob George, Ming‐Hua Zheng - HepatoBiliary Surgery and Nutrition 2023 cited by 88

  14. Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis

    Authors: , , , , , , , , , - Gut 2014 cited by 549

  15. Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology

    Authors: , , , - Hepatology 2020 cited by 128

  16. The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giada Sebastiani, Vincent Wai‐Sun Wong, Fredrik Åberg, Yu Jun Wong, Pian-hong Zhang, Francisco J. Bermúdez‐Silva, Yan Ni, Monica Lupșor‐Platon, Wah‐Kheong Chan, Nahúm Méndez‐Sánchez, Robert J. de Knegt, Shahinul Alam, Sombat Treeprasertsuk, Li Wang, Mulong Du, Tiejun Zhang, Ming‐Lung Yu, Huijie Zhang, Xingshun Qi, Xin Liu, Kanokwan Pinyopornpanish, Yu‐Chen Fan, Kaijun Niu, Josep C. Jiménez‐Chillarón, Ming‐Hua Zheng - Metabolism 2024 cited by 111

  17. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease

    Authors: , , , , , , , , - Gut 2012 cited by 359

  18. Liver enzymes, metabolomics and genome-wide association studies: From systems biology to the personalized medicine

    Authors: , - World Journal of Gastroenterology 2015 cited by 342

  19. Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update

    Authors: , , - Clinical Gastroenterology and Hepatology 2024 cited by 65

  20. Epigenetic Regulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , - Hepatology 2010 cited by 326

  21. Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD

    Authors: , , , , , , , - The American Journal of Gastroenterology 2020 cited by 66

  22. Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Saeed Hamid, Nilanka Perera, Khalid Alswat, Qiuwei Pan, Michelle T. Long, Isakov Va, Man Mi, Marco Arrese, Arun J. Sanyal, Shiv Kumar Sarin, Nathalie C. Leite, Luca Valenti, Philip N. Newsome, Hannes Hagström, Salvatore Petta, Hannele Yki‐Järvinen, Jörn M. Schattenberg, Marlén Castellanos, Isabelle Leclercq, Gulnara Aghayeva, Abdel‐Naser Elzouki, Ali Tumi, Ala I. Sharara, Asma Labidi, Faisal M. Sanai, Khaled Matar‎, Maen Almattooq, Maisam Akroush, Mustapha Benazzouz, Nabil Debzi, Maryam Alkhatry, Salma Barakat, Said A. Al‐Busafi, John Rwegasha, Wah Yang, Adwoa Agyei‐Nkansah, Christopher Opio, Mohammadjavad Sotoudeheian, Yu Jun Wong, Jacob George, Ming‐Hua Zheng - JHEP Reports 2024 cited by 94

  23. Systematic review with meta‐analysis: risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients

    Authors: , - Alimentary Pharmacology & Therapeutics 2017 cited by 230

  24. Liver mitochondrial DNA damage and genetic variability of Cytochrome b – a key component of the respirasome – drive the severity of fatty liver disease

    Authors: , , , , - Journal of Internal Medicine 2020 cited by 60